COLLIER COLLECTIVE, LLC for DRUG POLICY ACTION
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
1. Advocated for increased FY23 funding in the Labor, Health & Human Services, Education, and Related Agencies appropriations bill for HHS/CDC's Infectious Diseases & Opioid Epidemic program to expand access to overdose prevention and other harm reduction services to help prevent skyrocketing overdose deaths nationwide and prevent the transmission of infectious diseases. 2. Advocated on implementation of $30 million in American Rescue Plan Act funding to support overdose prevention, syringe services programs, and harm reduction services authorized and allocated by the American Rescue Plan Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNY COLLIER | — |
| DANIELLE NEAL | — |
Law Enforcement/Crime/Criminal Justice LAW
Advocated on the effectiveness of overdose prevention centers and the need for the Administration to permit and support this intervention in the U.S. to help save lives by reducing drug overdose deaths.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNY COLLIER | — |
Health Issues HCR
Advocated for not including or limiting the ban on the use of federal funds to purchase safe supplies for the use of drugs to reduce the transmission of infectious diseases and reduce drug overdoses in H.R. HR 7666, "The Restoring Hope for Mental Health and Well-Being Act of 2022."
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNY COLLIER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.